We are live on
!
Find out more
AA
AQR Arbitrage Portfolio holdings
AUM
$6.09B
1-Year Est. Return
27.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.86%
1 Year Est. Return
+27.01%
3 Year Est. Return
+77.25%
5 Year Est. Return
+160.09%
10 Year Est. Return
+1,244.43%
AUM
$2.78B
AUM Growth
-$65.9M
(-2.3%)
Cap. Flow
-$1.1B
Cap. Flow
% of AUM
-39.55%
Top 10 Holdings %
Top 10 Hldgs %
16.2%
Holding
1,575
New
503
Increased
22
Reduced
219
Closed
602
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMD
Cantel Medical Corporation
CMD
|
+$32.9M |
| 2 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$26.7M |
| 3 |
COHR
Coherent Inc
COHR
|
+$24.6M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$23.3M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$23.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
+$36.2M |
| 2 |
BMCH
BMC Stock Holdings, Inc
BMCH
|
+$35.8M |
| 3 |
NGHC
National General Holdings Corp
NGHC
|
+$29.7M |
| 4 |
CHNGU
Change Healthcare Inc. Tangible Equity Units
CHNGU
|
+$26.3M |
| 5 |
EV
Eaton Vance Corp.
EV
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.51% |
| 2 | Healthcare | 6.47% |
| 3 | Industrials | 4.82% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Technology | 3.86% |
Similar funds
JWBC
GA
CIS
EMPI
HCM
HPG
DTC
AWA
AQR Arbitrage's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Arbitrage held 1,575 positions worth $2.78B, down 2.3% from $2.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
AQR Arbitrage withdrew a net $1.1B in Q1 2021, closing 602 positions and reducing 219 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $36.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, AQR Arbitrage opened a new position in Cantel Medical Corporation worth $33.4M.
- AQR Arbitrage's largest Q1 2021 buy was Cantel Medical Corporation: 420,838 shares worth $33.4M.
- AQR Arbitrage added most to PRA Health Sciences, Inc. in Q1 2021, an estimated $23.3M increase.
- AQR Arbitrage's biggest Q1 2021 reduction was International Flavors & Fragrances Inc. 6.00% Tangible Equity Units, cutting an estimated $12.5M.
- AQR Arbitrage fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $36.2M.
- AQR Arbitrage's ten largest holdings make up 16% of its $2.78B portfolio in Q1 2021.
- AQR Arbitrage opened 503 new positions and closed 602 in Q1 2021.
- AQR Arbitrage's portfolio value fell 2.3% quarter-over-quarter to $2.78B.
Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.